BRKR Bruker Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: BRKR

Price (delayed)

$55.36

Market cap

$8.43B

P/E Ratio

N/A

Dividend/share

$0.2

EPS

-$0.24

Enterprise value

$9.97B

?
Relative Growth: Rel. Growth: 15
Relative Strength: Rel. Strength: 86
Relative Valuation: Rel. Valuation: 22
Relative Profitability: Rel. Profitability: 30

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scienti c instruments and high-value analytical and diagnostic solutions ...

Highlights
BRKR's equity is up by 35% YoY
Bruker's debt has decreased by 21% YoY and by 11% from the previous quarter
BRKR's EPS has dropped by 146% year-on-year and by 60% since the previous quarter
The net income has dropped by 115% year-on-year and by 35% since the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://www.bruker.com
Peers: TMO BIO WAT A

Key stats

What are the main financial stats of BRKR

BRKR stock price

How has the Bruker stock price performed over time
Intraday
-2.07%
1 week
-0.79%
1 month
21.16%
1 year
42.94%
YTD
17.51%
QTD
53.27%

Financial performance

How have Bruker's revenue and profit performed over time
Revenue
$3.46B
Gross profit
$1.57B
Operating income
$46.6M
Net income
-$11.6M
Gross margin
45.3%
Net margin
-0.3%
The net income has dropped by 115% year-on-year and by 35% since the previous quarter
Bruker's net margin has plunged by 113% YoY
BRKR's operating margin has shrunk by 80% YoY and by 35% QoQ
BRKR's operating income has dropped by 79% year-on-year and by 32% since the previous quarter

Price vs fundamentals

How does BRKR's price correlate with its fundamentals

Growth

What is Bruker's growth rate over time

Valuation

What is Bruker stock price valuation
BRKR P/E details
P/E
N/A
P/B
3.42
P/S
2.44
EV/EBIT
251.64
EV/EBITDA
37.21
EV/Sales
2.88
BRKR's EPS has dropped by 146% year-on-year and by 60% since the previous quarter
The stock's price to book (P/B) is 52% less than its 5-year quarterly average of 7.2 but 34% more than its last 4 quarters average of 2.6
BRKR's equity is up by 35% YoY
The stock's price to sales (P/S) is 46% more than its last 4 quarters average of 1.7 but 27% less than its 5-year quarterly average of 3.4

Efficiency

How efficient is Bruker business performance
BRKR's return on assets has dropped by 146% year-on-year and by 50% since the previous quarter
Bruker's return on equity has shrunk by 136% YoY and by 45% QoQ
Bruker's return on invested capital has shrunk by 79% YoY and by 40% QoQ
BRKR's return on sales has dropped by 79% year-on-year and by 42% since the previous quarter

Dividends

What is BRKR's dividend history
Dividend details
DPS
$0.2
Dividend yield
0.36%
Payout ratio
N/A
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Bruker financials performed over time
BRKR's total assets is 67% greater than its total liabilities
The quick ratio has decreased by 24% from the previous quarter and by 7% YoY
BRKR's total liabilities is down by 11% YoY and by 2.8% QoQ
Bruker's debt is 32% less than its equity
BRKR's debt to equity is down by 41% year-on-year and by 11% since the previous quarter
BRKR's equity is up by 35% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.